Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001641172-25-008461
Filing Date
2025-05-05
Accepted
2025-05-05 06:09:45
Documents
59
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 778089
2 EX-31.1 ex31-1.htm EX-31.1 18999
3 EX-31.2 ex31-2.htm EX-31.2 19723
4 EX-32.1 ex32-1.htm EX-32.1 7377
5 GRAPHIC form10-ka_001.jpg GRAPHIC 2011
6 GRAPHIC form10-ka_002.jpg GRAPHIC 6031
  Complete submission text file 0001641172-25-008461.txt   4256866

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE gcan-20241231.xsd EX-101.SCH 33535
8 XBRL CALCULATION FILE gcan-20241231_cal.xml EX-101.CAL 32556
9 XBRL DEFINITION FILE gcan-20241231_def.xml EX-101.DEF 169400
10 XBRL LABEL FILE gcan-20241231_lab.xml EX-101.LAB 290035
11 XBRL PRESENTATION FILE gcan-20241231_pre.xml EX-101.PRE 253552
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 463977
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56027 | Film No.: 25910788
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)